title: Dendritic cells in uninfected infants born to hepatitis B virus-positive mothers.
abstract: Plasmacytoid dendritic cells (pDCs) play a central role in antiviral immunity, detecting viruses via Toll-like receptors (TLR) and producing in response vast amounts of type I interferons (IFNs). Hepatitis B virus (HBV) causes chronic infection after vertical transmission. This study investigated whether an HBV-infected maternal environment might influence DC numbers and pDC function in uninfected infants. Blood was collected from inactive HBsAg carrier and control mothers and their infants at birth and 1 and 6 months of age. HBV DNA was measured in maternal and neonatal perinatal sera using real-time PCR. The circulating frequencies of myeloid DCs (mDCs) and pDCs were determined in the babies by flow cytometry. Peripheral blood mononuclear cells (PBMCs) and cord blood pDCs were stimulated with resiquimod, and alpha interferon (IFN-alpha) production and the pDC phenotype were assessed. The effect of the common-cold virus, rhinovirus (RV), on resiquimod stimulation was also determined. HBV DNA was detected in 62.3% of the mothers and 41% of their infants. DC numbers and pDC functions were similar between subjects and controls and were not correlated with maternal or neonatal viremia. RV infection did not induce pDC maturation until the age of 6 months, and it reduced TLR7-dependent resiquimod-induced IFN-alpha production similarly in both groups. Although the DC system is immature at birth, DCs of uninfected neonates of HBV-positive mothers are competent to initiate and maintain T-cell responses. RV is a weak inducer of IFN-alpha production until the age of 6 months and inhibits IFN-alpha responses triggered by the TLR7 pathway.
authors.affiliation: Alzaia Naviglio Pavese 8, 21036 Milan, Italy. lemonica.koumbi@gmail.com
authors.forename: Lemonica J
authors.initials: LJ
authors.lastname: Koumbi
authors.forename: Nikolaos G
authors.initials: NG
authors.lastname: Papadopoulos
authors.forename: Vassiliki
authors.initials: V
authors.lastname: Anastassiadou
authors.forename: Maria
authors.initials: M
authors.lastname: Machaira
authors.forename: Dimitris A
authors.initials: DA
authors.lastname: Kafetzis
authors.forename: Vassiliki
authors.initials: V
authors.lastname: Papaevangelou
mesh_terms: D000328:Adult; D016022:Case-Control Studies; D003713:Dendritic Cells / Q000276:immunology*; D005260:Female; D005434:Flow Cytometry; D006509:Hepatitis B / Q000276:immunology / Q000635:transmission; D006515:Hepatitis B virus / Q000276:immunology*; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008431:Maternal-Fetal Exchange / Q000276:immunology*; D009035:Mothers; D011247:Pregnancy; D014766:Viremia
chemical_list: D007093:Imidazoles; C402365:resiquimod
references.citation: Thorax. 1998 Nov;53(11):913-4
references.pmid: 10193386
references.citation: Hepatology. 2003 Nov;38(5):1075-86
references.pmid: 14578844
references.citation: J Gastroenterol Hepatol. 2005 Feb;20(2):234-42
references.pmid: 15683426
references.citation: Am J Respir Crit Care Med. 2005 Oct 15;172(8):1037-40
references.pmid: 15994468
references.citation: Science. 1999 Jun 11;284(5421):1835-7
references.pmid: 10364556
references.citation: Hum Immunol. 2002 Dec;63(12):1103-10
references.pmid: 12480253
references.citation: Am J Epidemiol. 1983 Feb;117(2):213-22
references.pmid: 6402925
references.citation: Blood. 2004 Feb 1;103(3):1030-2
references.pmid: 14504106
references.citation: Clin Exp Allergy. 2002 Apr;32(4):537-42
references.pmid: 11972599
references.citation: Allergy. 2009 Mar;64(3):375-86
references.pmid: 19175599
references.citation: Cell Immunol. 2002 Jul-Aug;218(1-2):74-86
references.pmid: 12470615
references.citation: Chin Med J (Engl). 2002 Sep;115(9):1380-2
references.pmid: 12411117
references.citation: J Infect Dis. 1985 Apr;151(4):599-603
references.pmid: 3973412
references.citation: J Clin Immunol. 2004 Nov;24(6):637-46
references.pmid: 15622448
references.citation: J Immunol. 2009 Oct 1;183(7):4440-8
references.pmid: 19734213
references.citation: Vaccine. 1998 Aug-Sep;16(14-15):1415-9
references.pmid: 9711781
references.citation: Clin Immunol. 2006 Dec;121(3):251-9
references.pmid: 17010668
references.citation: J Virol Methods. 2002 May 16;103(2):201-12
references.pmid: 12008014
references.citation: Proc Natl Acad Sci U S A. 1990 Sep;87(17):6599-603
references.pmid: 2395863
references.citation: Pathol Biol (Paris). 2002 Nov;50(9):568-75
references.pmid: 12490422
references.citation: Eur J Immunol. 2001 Oct;31(10):3026-37
references.pmid: 11592079
references.citation: J Virol. 2005 May;79(9):5507-15
references.pmid: 15827165
references.citation: Clin Immunol. 2008 Mar;126(3):243-50
references.pmid: 18201932
references.citation: Blood. 1994 Dec 15;84(12):4333-43
references.pmid: 7994049
references.citation: Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5598-603
references.pmid: 15034168
references.citation: Science. 2004 Mar 5;303(5663):1529-31
references.pmid: 14976261
references.citation: Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10006-10
references.pmid: 1438190
references.citation: Immunol Cell Biol. 2005 Oct;83(5):571-7
references.pmid: 16174109
references.citation: J Immunol. 2004 Nov 15;173(10):5935-43
references.pmid: 15528327
references.citation: J Hepatol. 2007 Dec;47(6):751-9
references.pmid: 17920718